MeMed is a host response company having developed innovative diagnostic host immune response tests that address complex clinical dilemmas and improve patient outcomes.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |